As a CDMO, Akums strives to provide comprehensive support to its business partners through a combination of backward and forward integration strategies. This approach ensures a robust risk mitigation plan for our partners and a consistent flow of products in the market, as well as the introduction of new therapy areas. Akums Plant at Kotdwar, produces a range of dosage forms in General, β-Lactum Injectable, and Penam.